TCPB yields 4.53% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, TCPB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCPB + JNJ for your $10,000?
TCPB is designed to provide broad exposure to the global fixed income market. It upholds its core claim by investing in a variety of US and foreign debt securities, of any maturity, including corporate and government bonds, asset- and mortgage-back securities, preferred stocks, and other income-producing debt securities. The fund primarily holds investment grades but may allocate up to 30% in high yield. It may also invest in USD-denominated foreign debt without limitation on top of holding foreign securities. In selecting constituents, the fund uses fundamental and other investment research techniques to assess a securitys value. Since the fund is actively managed, investment decisions are at the discretion of the adviser. TCPB may also utilize derivatives including US treasury future contracts to manage the funds duration and interest risk. The fund seeks a high level of current income.
Full TCPB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.